256 related articles for article (PubMed ID: 22425228)
1. The human IL-7 receptor gene: deletions, polymorphisms and mutations.
Mazzucchelli RI; Riva A; Durum SK
Semin Immunol; 2012 Jun; 24(3):225-30. PubMed ID: 22425228
[TBL] [Abstract][Full Text] [Related]
2. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract][Full Text] [Related]
3. Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.
Rodrigues GOL; Cramer SD; Winer HY; Hixon JA; Li W; Yunes JA; Durum SK
Adv Biol Regul; 2021 May; 80():100788. PubMed ID: 33578108
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.
Shochat C; Tal N; Bandapalli OR; Palmi C; Ganmore I; te Kronnie G; Cario G; Cazzaniga G; Kulozik AE; Stanulla M; Schrappe M; Biondi A; Basso G; Bercovich D; Muckenthaler MU; Izraeli S
J Exp Med; 2011 May; 208(5):901-8. PubMed ID: 21536738
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression.
Lundtoft C; Seyfarth J; Oberstrass S; Rosenbauer J; Baechle C; Roden M; Holl RW; Mayatepek E; Kummer S; Meissner T; Jacobsen M
J Autoimmun; 2019 Feb; 97():40-47. PubMed ID: 30342817
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7: Fuel for the autoimmune attack.
Dooms H
J Autoimmun; 2013 Sep; 45():40-8. PubMed ID: 23831438
[TBL] [Abstract][Full Text] [Related]
8. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
9. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
11. IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.
Butte MJ; Haines C; Bonilla FA; Puck J
Clin Immunol; 2007 Nov; 125(2):159-64. PubMed ID: 17827065
[TBL] [Abstract][Full Text] [Related]
12. IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?
Lundtoft C; Seyfarth J; Jacobsen M
Genes Immun; 2020 Feb; 21(2):83-90. PubMed ID: 31929513
[TBL] [Abstract][Full Text] [Related]
13. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
[TBL] [Abstract][Full Text] [Related]
15. T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy.
Ballesteros-Arias L; Silva JG; Paiva RA; Carbonetto B; Faísca P; Martins VC
J Immunol; 2019 Feb; 202(4):1137-1144. PubMed ID: 30651344
[TBL] [Abstract][Full Text] [Related]
16. IL-7 and TSLP receptors: twisted sisters.
Durum SK
Blood; 2014 Jul; 124(1):4-5. PubMed ID: 24993875
[TBL] [Abstract][Full Text] [Related]
17. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
[TBL] [Abstract][Full Text] [Related]
18. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency.
Kumaki S; Ishii N; Minegishi M; Tsuchiya S; Cosman D; Sugamura K; Konno T
Blood; 1999 Jan; 93(2):607-12. PubMed ID: 9885222
[TBL] [Abstract][Full Text] [Related]
19. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel nonsense mutation in the interleukin-7 receptor alpha gene in a Korean patient with severe combined immunodeficiency.
Jo EK; Kook H; Uchiyama T; Hakozaki I; Kim YO; Song CH; Park JK; Kanegane H; Tsuchiya S; Kumaki S
Int J Hematol; 2004 Nov; 80(4):332-5. PubMed ID: 15615257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
